1. Home
  2. RPTX vs SAMG Comparison

RPTX vs SAMG Comparison

Compare RPTX & SAMG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RPTX
  • SAMG
  • Stock Information
  • Founded
  • RPTX 2016
  • SAMG 2002
  • Country
  • RPTX Canada
  • SAMG United States
  • Employees
  • RPTX N/A
  • SAMG N/A
  • Industry
  • RPTX Biotechnology: Pharmaceutical Preparations
  • SAMG Investment Managers
  • Sector
  • RPTX Health Care
  • SAMG Finance
  • Exchange
  • RPTX Nasdaq
  • SAMG Nasdaq
  • Market Cap
  • RPTX 152.4M
  • SAMG 171.2M
  • IPO Year
  • RPTX 2020
  • SAMG 2013
  • Fundamental
  • Price
  • RPTX $2.97
  • SAMG $18.29
  • Analyst Decision
  • RPTX Strong Buy
  • SAMG
  • Analyst Count
  • RPTX 1
  • SAMG 0
  • Target Price
  • RPTX $10.00
  • SAMG N/A
  • AVG Volume (30 Days)
  • RPTX 113.0K
  • SAMG 24.9K
  • Earning Date
  • RPTX 11-07-2024
  • SAMG 10-31-2024
  • Dividend Yield
  • RPTX N/A
  • SAMG 4.40%
  • EPS Growth
  • RPTX N/A
  • SAMG N/A
  • EPS
  • RPTX N/A
  • SAMG 0.79
  • Revenue
  • RPTX $66,524,000.00
  • SAMG $120,231,000.00
  • Revenue This Year
  • RPTX $13.36
  • SAMG $7.10
  • Revenue Next Year
  • RPTX N/A
  • SAMG $5.89
  • P/E Ratio
  • RPTX N/A
  • SAMG $22.68
  • Revenue Growth
  • RPTX 18.19
  • SAMG 2.45
  • 52 Week Low
  • RPTX $2.71
  • SAMG $13.93
  • 52 Week High
  • RPTX $8.49
  • SAMG $18.77
  • Technical
  • Relative Strength Index (RSI)
  • RPTX 39.57
  • SAMG 58.97
  • Support Level
  • RPTX $2.81
  • SAMG $18.10
  • Resistance Level
  • RPTX $4.05
  • SAMG $18.77
  • Average True Range (ATR)
  • RPTX 0.27
  • SAMG 0.44
  • MACD
  • RPTX -0.08
  • SAMG 0.02
  • Stochastic Oscillator
  • RPTX 16.92
  • SAMG 80.95

About RPTX Repare Therapeutics Inc.

Repare Therapeutics Inc is a precision medicine oncology company focused on the development of synthetic lethality-based therapies for patients with cancer. The Company's focus is the research, development and commercialization of precision oncology drugs targeting specific vulnerabilities of tumors in genetically defined patient populations. The company derives maximum revenue from Canada.

About SAMG Silvercrest Asset Management Group Inc.

Silvercrest Asset Management Group Inc is a wealth management firm focused on providing financial advisory and related family office services to ultra-high net-worth individuals and institutional investors. It advises clients on traditional investment strategies focused on equities, fixed income and cash as well as non-traditional investment strategies including hedge funds, private equity funds, real estate and commodities. It also provides clients with family office services and related administrative services, which include financial planning, tax planning and preparation, partnership accounting and fund administration, and consolidated wealth reporting. The company derives revenues principally from assets under management.

Share on Social Networks: